rituximab,tazemetostat,lenalidomide
epizyme,eisai
['symphony-1', 'lenalidomide', 'tazemetostat', 'lymsm', ' lena', 'ritux']
congress| #ash22 presents phase ib results of the symphony-1 trial of tazemetostat + r2 in patients with r/r #fl. the data shows a manageable safety profile, with no new safety signals. efficacy was high, regardless of mutation status.
#lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm